中晚期食管癌患者同期放化疗所致食管炎的中药防治分析

An analysis of preventing esophagitis in concurrent radiotherapy and chemotherapy in patients with advanced esophageal carcinoma with TCM medicine

目的:分析中晚期食管癌同期放化疗所致食管炎的中药防治措施。方法:研究对象为2014年8月12日-2015年6月23日我院80例中晚期食管癌患者,根据不同治疗方案,均分为两组。两组均予以同期放化疗,对照组使用常规药物,在此基础上,观察组予以中药方剂。观察两组存活、食管癌及其他并发症发生情况。结果:观察组1年及2年存活概率分别为75.00%、62.50%,高于对照组指标,P<0.05;观察组食管炎发生情况优于对照组,两组Ⅱ度、Ⅰ度、0度数据对比差异大,P<0.05;观察组其他并发症发生概率(7.50%)低于对照组,P<0.05。结论:中晚期食管癌同期放化疗治疗患者,易引发食管炎症状,予以中药防治,效果较佳。

Objective:To analyze the preventive measures of TCM medicine for esophageal inflammation caused by concurrent radiotherapy and chemotherapy.Methods:80 patients with advanced esophageal carcinoma in our hospital were divided into two groups according to different treatment schemes.Both groups were given concurrent radiotherapy and chemotherapy.The control group was given conventional medicine.The observation group was given TCM medicine more.The survival,esophageal cancer and other complications in two groups were observed.Results:The survival probability of 1 year and 2 years were 75.00%,62.50%respectively in the observation group,and higher than the control group,P<0.05.The incidence of esophagitis in the observation group was better than the control group,two groups ofⅡdegree,Ⅰdegree,0 degree between two groups showed significant differences,P<0.05.the probability of other complications was 7.50%in the observation group was lower than the control group,P<0.05.Conclusion:Concurrent radiotherapy and chemotherapy for patients with advanced esophageal carcinoma are easy to induce esophagitis symptoms,and it is better to prevent and treat them.